Patents by Inventor Terry Riss

Terry Riss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070178545
    Abstract: A method to detect the presence or amount of at least one molecule for an enzyme-mediated reaction in a multiplex luminogenic/nonluminogenic assay is provided.
    Type: Application
    Filed: July 20, 2006
    Publication date: August 2, 2007
    Inventors: Andrew Niles, Terry Riss
  • Publication number: 20070048812
    Abstract: A method to detect proteasome activity in permeabilized cells, and optionally in a multiplex assay to detect presence or amount of at least one molecule for a different enzyme-mediated reaction, is provided.
    Type: Application
    Filed: August 25, 2006
    Publication date: March 1, 2007
    Inventors: Richard Moravec, Terry Riss
  • Publication number: 20060166294
    Abstract: Disclosed are antibodies that specifically recognize the new amino terminus of a protein cleaved by a protease during apoptosis. Methods of using and making the antibodies are also provided. The antibodies are particularly useful in methods of detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis.
    Type: Application
    Filed: March 24, 2006
    Publication date: July 27, 2006
    Applicant: Promega Corporation
    Inventor: Terry Riss
  • Patent number: 7037664
    Abstract: Disclosed are antibodies that specifically recognize the new amino terminus of a protein cleaved by a protease during apoptosis. Methods of using and making the antibodies are also provided. The antibodies are particularly useful in methods of detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis.
    Type: Grant
    Filed: December 3, 2001
    Date of Patent: May 2, 2006
    Assignee: Promega Corporation
    Inventor: Terry Riss
  • Publication number: 20050186557
    Abstract: Disclosed are a method and a corresponding kit for determining the cytotoxicity of a test agent. The method includes the steps of adding a pre-determined amount of the test agent to a vessel containing living cells in culture medium. The cells are then incubated for a pre-determined amount of time. To the cells and culture medium is then added a reagent mixture that is non-toxic to the living cells. In the preferred embodiment, the reagent mixture contains a solvent, a dye, an electron transfer agent, a substrate for a cytoplasmic enzyme having a half-life greater than two hours and NAD+. The contents of the vessel are then measured for production of the reduced state of the dye, the production of the reduced state of the dye being caused by a cytoplasmic enzyme specific for the substrate in the reagent mixture. In the preferred embodiment, the production of the reduced state of the dye is caused by lactate dehydrogenase released from dead and dying cells within the vessel.
    Type: Application
    Filed: March 24, 2005
    Publication date: August 25, 2005
    Inventors: Terry Riss, Richard Moravec
  • Publication number: 20050164321
    Abstract: A method to detect the presence or amount of at least one molecule for an enzyme-mediated reaction in a multiplex luminogenic/nonluminogenic assay is provided.
    Type: Application
    Filed: January 22, 2004
    Publication date: July 28, 2005
    Inventors: Terry Riss, Andrew Niles, Richard Moravec
  • Publication number: 20020102268
    Abstract: Disclosed are antibodies that specifically recognize the new amino terminus of a protein cleaved by a protease during apoptosis. Methods of using and making the antibodies are also provided. The antibodies are particularly useful in methods of detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis.
    Type: Application
    Filed: December 3, 2001
    Publication date: August 1, 2002
    Applicant: Promega Corporation
    Inventor: Terry Riss
  • Patent number: 6350452
    Abstract: Disclosed are antibodies that specifically recognize the new amino terminus of a protein cleaved by a protease during apoptosis. Methods of using and making the antibodies are also provided. The antibodies are particularly useful in methods of detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis.
    Type: Grant
    Filed: December 8, 1999
    Date of Patent: February 26, 2002
    Assignee: Promega Corporation
    Inventor: Terry Riss